 | This article includes a list of general references, but it lacks sufficient corresponding inline citations .(January 2022) |
Andres Metspalu | |
|---|---|
 | |
| Born | March 11, 1951 Lääne-Viru County, Estonia |
| Nationality | Estonian |
| Occupation | Geneticist |
| Known for | Director of the Estonian Genome Center at the University of Tartu |
Andres Metspalu (born 11 March 1951) is an Estonian geneticist and member of the Estonian Academy of Sciences.
Metspalu was born on 11 March 1951 in Lääne-Viru County. [1] In 1969 he graduated from the Rakke High School. In 1976 he graduated from the University of Tartu, Faculty of Medicine, as a physician. In 1979 he obtained a Ph.D. in Molecular Biology from the Institute of Molecular Genetics at the National Academy of Sciences of Ukraine in Kiev. His thesis was on the structure and function of the Eukaryotic ribosome. [2]
From 1976 to 1980, Metspalu was a junior scientist at Laboratory of Molecular Biology, University of Tartu. From 1981 to 1982, he was an IREX fellow at Columbia University. He returned to the Laboratory of Molecular Biology as a Senior Scientist, then from 1985 to 1992 was head of the Laboratory of Gene Expression at Tartu University. From 1986 to 1992, he was Research Director of the Estonian Biocentre. During that period he also visited the Max Planck Institute for Molecular Genetics, the University of Tampere, and the University of Hamburg. [2]
In 1992, Metspalu was appointed to the Chair of Biotechnology at the University of Tartu, and head of the Gene Technology Laboratory, Estonian Biocentre. In 1993 he spent three months at the University of Hamburg's H. Pette Institute for Experimental Immunolog, and then from 1993 to 1994 was a visiting professor at Baylor College of Medicine's Dept. of Molecular and Human Genetics with C. Thomas Caskey. From 1996 to 2007, he was again head of the Molecular Diagnostics Centre at Tartu University Clinics. In 1999, he was founder and Chairman of Asper Biotech Ltd. in Tartu. During that period he visited the International Agency for Research on Cancer (1999-2000) and was founder and Chief Scientific Officer at EGeen International Inc. (Foster City, California; 2002-2004). Since 2007 he has been Director of the Estonian Genome Center at the University of Tartu. [2]
 | This section of a biography of a living person does not include any references or sources .(December 2012) |
Metspalu became interested in DNA, genes, and ribosomes in high school, but made his final decision to follow this subject in his fourth semester of molecular biology, when he began practical research in biochemistry under Artur Lind. In 1981 Metspalu had the opportunity to work as a research fellow in Columbia and Yale Universities in the United States. On his returning from America, he contributed knowledge to the molecular biology lab at the University of Tartu, which obtained a new generation of devices and began to undertake modern genetic science. Metspalu's major fields of research are genomics and genetic engineering, human genome research methods for large variation in gene banks; genetics and complex diseases, the relationship of genes, environmental factors, lifestyle, and state of health between the molecular and genetic analysis in developing the technology of DNA chip technology.
Metspalu is active in various research organizations in Estonia and abroad. He is president of the Estonian Human Genetics Society and a member of the Steering Committee of the Genomics Center of Excellence, as well as the Human Genetics Society Steering Committee of the Human Genome Organization, American Society of Human Genetics, and ScanBalt Academy. [2]
On two occasions, Metspalu won the Science Prize (1980, 2003). In 2001 he was awarded the Estonian Red Cross Order of Merit Class III. In 2002 he won the French Award "Prix de la Garantie Medicale et Chirurgicale" and in 2003 was made Chevalier of the "Ordre des Palmes Académiques". In 2010 he was made an honorary member of Vilnius University, with an honorary doctorate. [2] In 2017, he was awarded the Baltic Assembly Prize for Science in recognition of "his innovative, diverse and lasting contribution to gene technology and molecular diagnostic". [3]
Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.
Molecular genetics is a branch of biology that addresses how differences in the structures or expression of DNA molecules manifests as variation among organisms. Molecular genetics often applies an "investigative approach" to determine the structure and/or function of genes in an organism's genome using genetic screens.
Toomas Kivisild is an Estonian population geneticist. He graduated as a biologist and received his PhD in Genetics, from University of Tartu, Estonia, in 2000. Since then he has worked as a postdoctoral research fellow in the School of Medicine, at Stanford University (2002-3), Estonian Biocentre, as the Professor of Evolutionary Biology, University of Tartu (2005-6), and as a Lecturer and Reader in Human Evolutionary Genetics in the Department of Archaeology and Anthropology at the University of Cambridge (2006-2018). From 2018 he is a professor in the Department of Human Genetics at KU Leuven and a senior researcher at the Institute of Genomics, University of Tartu.
George McDonald Church is an American geneticist, molecular engineer, chemist, serial entrepreneur, and pioneer in personal genomics and synthetic biology. He is the Robert Winthrop Professor of Genetics at Harvard Medical School, Professor of Health Sciences and Technology at Harvard University and Massachusetts Institute of Technology, and a founding member of the Wyss Institute for Biologically Inspired Engineering at Harvard. Through his Harvard lab Church has co-founded around 50 biotech companies pushing the boundaries of innovation in the world of life sciences and making his lab as a hotbed of biotech startup activity in Boston. In 2018, the Church lab at Harvard made a record by spinning off 16 biotech companies in one year. The Church lab works on research projects that are distributed in diverse areas of modern biology like developmental biology, neurobiology, info processing, medical genetics, genomics, gene therapy, diagnostics, chemistry & bioengineering, space biology & space genetics, and ecosystem. Research and technology developments at the Church lab have impacted or made direct contributions to nearly all "next-generation sequencing (NGS)" methods and companies. In 2017, Time magazine listed him in Time 100, the list of 100 most influential people in the world. In 2022, he was featured among the most influential people in biopharma by Fierce Pharma, and was listed among the top 8 famous geneticists of all time in human history. As of January 2023, Church serves as a member of the Bulletin of the Atomic Scientists' Board of Sponsors.
In biology, the word gene has two meanings. The Mendelian gene is a basic unit of heredity. The molecular gene is a sequence of nucleotides in DNA, that is transcribed to produce a functional RNA. There are two types of molecular genes: protein-coding genes and non-coding genes.
Elliot Meyerowitz is an American biologist.
David Botstein is an American biologist serving as the chief scientific officer of Calico. He served as the director of the Lewis-Sigler Institute for Integrative Genomics at Princeton University from 2003 to 2013, where he remains an Anthony B. Evnin Professor of Genomics.
The Richard Lounsbery Award is given to American and French scientists, 45 years or younger, in recognition of "extraordinary scientific achievement in biology and medicine."
David Haussler is an American bioinformatician known for his work leading the team that assembled the first human genome sequence in the race to complete the Human Genome Project and subsequently for comparative genome analysis that deepens understanding the molecular function and evolution of the genome.
Quattromed Ltd is one of the leading biotechnology companies in Estonia providing medical diagnostics services and performing custom research programs for the biopharmaceutical industry. As of March 2009, Icosagen AS is the new business name of the former Quattromed Ltd.
Maynard Victor Olson is an American chemist and molecular biologist. As a professor of genome sciences and medicine at the University of Washington, be became a specialist in the genetics of cystic fibrosis, and one of the founders of the Human Genome Project. During his years at Washington University in St. Louis, he also led efforts to develop yeast artificial chromosomes that allowed for the study of large portions of the human genome.
Takashi Gojobori is a Japanese molecular biologist, Vice-Director of the National Institute of Genetics (NIG) and the DNA Data Bank of Japan (DDBJ) at NIG, in Mishima, Japan. Gojobori is a Distinguished Professor at King Abdullah University of Science and Technology (KAUST) in Thuwal, Saudi Arabia. He is a Professor of Bioscience and Acting Director at the Computational Bioscience Research Center at KAUST.
The following outline is provided as an overview of and topical guide to genetics:
Gerald Mayer Rubin is an American biologist, notable for pioneering the use of transposable P elements in genetics, and for leading the public project to sequence the Drosophila melanogaster genome. Related to his genomics work, Rubin's lab is notable for development of genetic and genomics tools and studies of signal transduction and gene regulation. Rubin also serves as a vice president of the Howard Hughes Medical Institute and executive director of the Janelia Research Campus.
Dietrich A. Stephan is an American human geneticist and entrepreneur who works in personalized medicine. Stephan is currently CEO of NeuBase Therapeutics and a General Partner in Cyto Ventures. Before NeuBase, Stephan was CEO of LifeX and Chairman and Professor of Human Genetics at the University of Pittsburgh. Prior, he was founding Chairman of the Neurogenomics Division at the Translational Genomics Research Institute. Stephan has founded or co-founded 14 biotechnology companies and advised many others. Stephan was co-founder of Navigenics, a personal genetics company.
Aravinda Chakravarti is a human geneticist and expert in computational biology, and Director of the Center For Human Genetics & Genomics at New York University. He was the 2008 President of the American Society of Human Genetics. Chakravarti became a co-Editor-in-Chief of the journal Genome Research in 1995, and of the Annual Review of Genomics and Human Genetics' in 2005.
Riin Tamm is an Estonian geneticist and a science popularizer. She is the head of the Department of Youth and Talent Policy within the Estonian Ministry of Education and Research. She has previously served as the director of University of Tartu Youth Academy.
The Estonian Society of Human Genetics (ESTSHG) is a non-profit organization that promotes research and communication between scientists involved in human and medical genetics.
B K Thelma commonly known as Bittianda Kuttapa Thelma is a professor in the Department of Genetics at the University of Delhi, South Campus, New Delhi, India. She is the Principal investigator and Co-ordinator of the Centre of excellence on Genomes Sciences and Predictive Medicine funded by the Govt. of India. She is also the Co-ordinator of a major project on newborn screening for inborn errors of metabolism in Delhi state which aims to demonstrate the feasibility of mandatory screening of newborns in the country and to generate epidemiological data for the testable IEMs in the genetically distinct Indian population, for the first time.
| International | |
|---|---|
| National | |
| Academics | |
